Truvestments Capital »

Theravance Biopharma shares owned by Truvestments Capital

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Truvestments Capital from 13F filings

Historical chart of Truvestments Capital investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Truvestments Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Truvestments Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.4k 200 17.00

More positions owned by Truvestments Capital

NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Corning Incorporated (GLW)
Broadcom (AVGO)
Apple (AAPL)
Caterpillar (CAT)
Applied Materials (AMAT)
Celestica (CLS)
Dell Technologies CL C (DELL)
Qualcomm (QCOM)
Marvell Technology (MRVL)
Ryder System (R)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Johnson & Johnson (JNJ)

View all positions for Truvestments Capital

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
BlackRock
Newtyn Management
Irenic Capital Management
Vanguard Capital Management
Two Sigma Investments
D. E. Shaw & Co
Acadian Asset Management
Geode Capital Management
Dimensional Fund Advisors
Mackenzie Financial
Oasis Management
Citadel Advisors
UBS Group

View all funds holding Theravance Biopharma